Back
Madrigal Pharmaceuticals, Inc. 10K Form
Sell
30
MDGL
Madrigal Pharmaceuticals, Inc.
Last Price:
$438.45
Seasonality Move:
1.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MDGL News And Ratings
See the #1 stock for the next 7 days that we like better than MDGL
MDGL Financial Statistics
Sales & Book Value
| Annual Sales: | $958.4M |
|---|---|
| Cash Flow: | $-133.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $26.39 |
| Price / Book: | 16.26 |
Profitability
| EPS (TTM): | -12.86410 |
|---|---|
| Net Income (TTM): | $-288.3M |
| Gross Margin: | $900.7M |
| Return on Equity: | -42.53% |
| Return on Assets: | -25.39% |
Madrigal Pharmaceuticals, Inc. Earnings Forecast
Key Madrigal Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 24 years for MDGL is 93.98%.
-
The Selling, General & Administrative Expenses for MDGL have been equal to 84.91% of Gross Profit Margin.
-
The Research & Development expenses have been 40.38% of Revenue.
-
The Net Earning history of MDGL is -30.08% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 9 years.
Madrigal Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MDGL |
| CUSIP: | 558868 |
| Website: | madrigalpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.58 |
|---|---|
| Current Ratio: | 4.01 |
| Quick Ratio: | 3.62 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 33.73 |
MDGL Technical Analysis vs Fundamental Analysis
Sell
30
Madrigal Pharmaceuticals, Inc. (MDGL)
is a Sell
Is Madrigal Pharmaceuticals, Inc. a Buy or a Sell?
-
Madrigal Pharmaceuticals, Inc. stock is rated a SellThe current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $431.53. The Score for MDGL is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.